Home » FDA Approves Once-Monthly Osteoporosis Drug
FDA Approves Once-Monthly Osteoporosis Drug
The FDA has approved a once-monthly version of Boniva tablets, an osteoporosis treatment marketed jointly by Roche and GlaxoSmithKline.
The FDA approved a daily version of Boniva (ibandronate sodium) in 2003, but the companies decided not to launch the drug until it developed a more convenient dosing method. Most rival osteoporosis drugs, such as Merck's Fosamax (alendronate sodium) and sanofi-aventis' Actonel (risedronate sodium), must be taken either daily or weekly.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May